Nyxoah implants first patient in U.S. BREATHE study for Genio

Nyxoah SA said the first patient has been implanted in BREATHE, its U.S. post-approval study of the Genio system. The multicenter, prospective single-arm study will enroll up to 229 adults and follow them up to five years.